-
1
-
-
71749105762
-
-
SINGULAIR (montelukast sodium) prescribing information [package insert, Whitehouse Station NJ, Merck & Co, Inc, 2009
-
SINGULAIR (montelukast sodium) prescribing information [package insert]. Whitehouse Station (NJ): Merck & Co, Inc., 2009.
-
-
-
-
3
-
-
33847391959
-
Mental disorders among adults with asthma: results from the World Mental Health Survey
-
Scott K.M., Von Korff M., Ormel J., Zhang M., Bruffaerts R., Alonso J., et al. Mental disorders among adults with asthma: results from the World Mental Health Survey. Gen Hosp Psychiatry 29 (2007) 123-133
-
(2007)
Gen Hosp Psychiatry
, vol.29
, pp. 123-133
-
-
Scott, K.M.1
Von Korff, M.2
Ormel, J.3
Zhang, M.4
Bruffaerts, R.5
Alonso, J.6
-
4
-
-
57349157753
-
The asthma/mental health nexus in a population-based sample of the United States
-
Chun T.H., Weitzen S.H., and Fritz G.K. The asthma/mental health nexus in a population-based sample of the United States. Chest 134 (2008) 1176-1182
-
(2008)
Chest
, vol.134
, pp. 1176-1182
-
-
Chun, T.H.1
Weitzen, S.H.2
Fritz, G.K.3
-
5
-
-
57049127774
-
Depression and anxiety in the United States: findings from the 2006 Behavioral Risk Factor Surveillance System
-
Strine T.W., Mokdad A.H., Balluz L.S., Gonzalez O., Crider R., Berry J.T., et al. Depression and anxiety in the United States: findings from the 2006 Behavioral Risk Factor Surveillance System. Psychiatric Services 59 (2008) 1383-1390
-
(2008)
Psychiatric Services
, vol.59
, pp. 1383-1390
-
-
Strine, T.W.1
Mokdad, A.H.2
Balluz, L.S.3
Gonzalez, O.4
Crider, R.5
Berry, J.T.6
-
6
-
-
34247229666
-
Developmental and behavioral comorbidities of asthma in children
-
Blackman J.A., and Gurka M.J. Developmental and behavioral comorbidities of asthma in children. J Dev Behav Pediatr 28 (2007) 92-99
-
(2007)
J Dev Behav Pediatr
, vol.28
, pp. 92-99
-
-
Blackman, J.A.1
Gurka, M.J.2
-
7
-
-
35248851253
-
The prevalence of DSM-IV anxiety and depressive disorders in youth with asthma compared with controls
-
Katon W., Lozano P., Russo J., McCauley E., Richardson L., and Bush T. The prevalence of DSM-IV anxiety and depressive disorders in youth with asthma compared with controls. J Adolesc Health 41 (2007) 455-463
-
(2007)
J Adolesc Health
, vol.41
, pp. 455-463
-
-
Katon, W.1
Lozano, P.2
Russo, J.3
McCauley, E.4
Richardson, L.5
Bush, T.6
-
8
-
-
70249116131
-
-
and, SINGULAIR, March 27, 2008. Available at:, Accessed August 10, 2009
-
US Food and Drug Administration. Early communication about an ongoing safety review of montelukast (SINGULAIR), March 27, 2008. Available at: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm095019.htm. Accessed August 10, 2009.
-
Early communication about an ongoing safety review of montelukast
-
-
Food, U.S.1
-
9
-
-
84856117141
-
-
and, SINGULAIR, January 13, 2009. Available at:, Accessed August 10, 2009
-
US Food and Drug Administration. Update of safety review follow-up to the March 27, 2008, communication about the ongoing safety review of montelukast (SINGULAIR), January 13, 2009. Available at: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm079523.htm. Accessed August 10, 2009.
-
Update of safety review follow-up to the March 27, 2008, communication about the ongoing safety review of montelukast
-
-
Food, U.S.1
-
10
-
-
71749116100
-
-
and, June 12, 2009. Available at:, Accessed August 10, 2009
-
US Food and Drug Administration. Updated information on leukotriene inhibitors: montelukast (marketed as Singulair), zafirlukast (marketed as Accolate), and zileuton (marketed as Zyflo and Zyflo CR), June 12, 2009. Available at: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm165489.htm. Accessed August 10, 2009.
-
Updated information on leukotriene inhibitors: Montelukast (marketed as Singulair), zafirlukast (marketed as Accolate), and zileuton (marketed as Zyflo and Zyflo CR)
-
-
Food, U.S.1
-
11
-
-
0000936448
-
The analysis of several 2x2 contingency tables
-
Zelen M. The analysis of several 2x2 contingency tables. Biometrika 58 (1971) 129-137
-
(1971)
Biometrika
, vol.58
, pp. 129-137
-
-
Zelen, M.1
-
12
-
-
71749103730
-
Center for Drug Evaluation and Research (CDER)
-
and, March, Available at:, Accessed August 10, 2009
-
US Food and Drug Administration, Center for Drug Evaluation and Research (CDER). Guidance: drug safety information-FDA's communication to the public, March 2007. Available at: http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm064993.htm. Accessed August 10, 2009.
-
(2007)
Guidance: Drug safety information-FDA's communication to the public
-
-
Food, U.S.1
-
13
-
-
38149028546
-
Changes in allergy symptoms and depression scores are positively correlated in patients with recurrent mood disorders exposed to seasonal peaks in aeroallergens
-
Postolache T.T., Lapidus M., Sander E.R., Langenberg P., Hamilton R.G., Soriano J.J., et al. Changes in allergy symptoms and depression scores are positively correlated in patients with recurrent mood disorders exposed to seasonal peaks in aeroallergens. Sci World J 17 (2007) 1968-1977
-
(2007)
Sci World J
, vol.17
, pp. 1968-1977
-
-
Postolache, T.T.1
Lapidus, M.2
Sander, E.R.3
Langenberg, P.4
Hamilton, R.G.5
Soriano, J.J.6
-
14
-
-
0025736639
-
Depression and allergies: survey of a nonclinical population
-
Bell I., Jasnoski M., Kagan J., and King D. Depression and allergies: survey of a nonclinical population. Psychother Psychosom 55 (1991) 24-31
-
(1991)
Psychother Psychosom
, vol.55
, pp. 24-31
-
-
Bell, I.1
Jasnoski, M.2
Kagan, J.3
King, D.4
-
15
-
-
0032755767
-
Cross-sectional associations of asthma, hay fever, and other allergies with major depression and low-back pain among adults aged 20-39 years in the United States
-
Hurwitz E.L., and Morgenstern H. Cross-sectional associations of asthma, hay fever, and other allergies with major depression and low-back pain among adults aged 20-39 years in the United States. Am J Epidemiol 150 (1999) 1107-1116
-
(1999)
Am J Epidemiol
, vol.150
, pp. 1107-1116
-
-
Hurwitz, E.L.1
Morgenstern, H.2
-
16
-
-
0037102001
-
Association between skin test diagnosed atopy and professionally diagnosed depression: a Northern Finland 1966 Birth Cohort study
-
Timonen M., Jokelainen J., Silvennoinen-Kassinen S., Herva A., Zitting P., Xu B., et al. Association between skin test diagnosed atopy and professionally diagnosed depression: a Northern Finland 1966 Birth Cohort study. Biol Psychiatry 52 (2002) 349-355
-
(2002)
Biol Psychiatry
, vol.52
, pp. 349-355
-
-
Timonen, M.1
Jokelainen, J.2
Silvennoinen-Kassinen, S.3
Herva, A.4
Zitting, P.5
Xu, B.6
-
17
-
-
0041589191
-
Atopy and depression: results from the Northern Finland 1966 Birth Cohort Study
-
Timonen M., Jokelainen J., Hakko H., Silvennoinen-Kassinen S., Meyer-Rochow V.P., Herva A., et al. Atopy and depression: results from the Northern Finland 1966 Birth Cohort Study. Mol Psychiatry 8 (2003) 738-744
-
(2003)
Mol Psychiatry
, vol.8
, pp. 738-744
-
-
Timonen, M.1
Jokelainen, J.2
Hakko, H.3
Silvennoinen-Kassinen, S.4
Meyer-Rochow, V.P.5
Herva, A.6
-
18
-
-
0037841747
-
Presence of atopy in first-degree relatives as a predictor of a female proband's depression: Results from the Northern Finland 1966 Birth Cohort
-
Timonen M., Jokelainen J., Herva A., Zitting P., Meyer-Rochow V.P., and Räsänen P. Presence of atopy in first-degree relatives as a predictor of a female proband's depression: Results from the Northern Finland 1966 Birth Cohort. J Allergy Clin Immunol 111 (2003) 1249-1254
-
(2003)
J Allergy Clin Immunol
, vol.111
, pp. 1249-1254
-
-
Timonen, M.1
Jokelainen, J.2
Herva, A.3
Zitting, P.4
Meyer-Rochow, V.P.5
Räsänen, P.6
-
19
-
-
33744487383
-
Major depression and allergy: does neuroticism explain the relationship?
-
Goodwin R.D., Castro M., and Kovacs M. Major depression and allergy: does neuroticism explain the relationship?. Psychosom Med 68 (2006) 94-98
-
(2006)
Psychosom Med
, vol.68
, pp. 94-98
-
-
Goodwin, R.D.1
Castro, M.2
Kovacs, M.3
-
20
-
-
71749087802
-
-
ADVAIR® DISKUS® 100/50 (fluticasone propionate 100 mcg and salmeterol 50 mcg inhalation powder) prescribing information [package insert, Research Triangle Park NC, GlaxoSmithKline, 2009
-
ADVAIR® DISKUS® 100/50 (fluticasone propionate 100 mcg and salmeterol 50 mcg inhalation powder) prescribing information [package insert]. Research Triangle Park (NC): GlaxoSmithKline, 2009.
-
-
-
-
21
-
-
71749099450
-
-
FLOVENT® DISKUS® 50 mcg (fluticasone propionate inhalation powder, 50 mcg) prescribing information. Research Triangle Park (NC): GlaxoSmithKline, 2008.
-
FLOVENT® DISKUS® 50 mcg (fluticasone propionate inhalation powder, 50 mcg) prescribing information. Research Triangle Park (NC): GlaxoSmithKline, 2008.
-
-
-
-
22
-
-
71749120022
-
-
PULMICORT FLEXHALER™ (budesonide) Aerosol, Powder prescribing information. Wilmington (DE): AstraZeneca LP, 2008.
-
PULMICORT FLEXHALER™ (budesonide) Aerosol, Powder prescribing information. Wilmington (DE): AstraZeneca LP, 2008.
-
-
-
-
23
-
-
22044450186
-
Public-released version of the Adverse Event Reporting System (AERS) database
-
[letter] author reply 357-9
-
Strauss A., Gould A.L., Nelsen L.M., Wiholm B.E., and Jones J.K. Public-released version of the Adverse Event Reporting System (AERS) database. [letter]. Clin Ther 27 (2005) 355-357 author reply 357-9
-
(2005)
Clin Ther
, vol.27
, pp. 355-357
-
-
Strauss, A.1
Gould, A.L.2
Nelsen, L.M.3
Wiholm, B.E.4
Jones, J.K.5
-
24
-
-
71749096662
-
-
Quarter, Available at:, Accessed August 10, 2009
-
The Institute for Safe Medication Practices. QuarterWatch: 2008 Quarter 2. Available at: http://www.ismp.org/QuarterWatch/200901.pdf. Accessed August 10, 2009.
-
(2008)
QuarterWatch
, pp. 2
-
-
-
26
-
-
42049112159
-
Individual case safety reports in children in commonly used drug groups-signal detection
-
Brunlöf G., Tukukino C., and Wallerstedt S.M. Individual case safety reports in children in commonly used drug groups-signal detection. BMC Clin Pharmacol 8 (2008) 1
-
(2008)
BMC Clin Pharmacol
, vol.8
, pp. 1
-
-
Brunlöf, G.1
Tukukino, C.2
Wallerstedt, S.M.3
-
27
-
-
53049100875
-
Montelukast and emotional well-being as a marker for depression: results from three randomized, double-masked clinical trials
-
Holbrook J.T., and Harik-Khan R. Montelukast and emotional well-being as a marker for depression: results from three randomized, double-masked clinical trials. J Allergy Clin Immunol 122 (2008) 828-829
-
(2008)
J Allergy Clin Immunol
, vol.122
, pp. 828-829
-
-
Holbrook, J.T.1
Harik-Khan, R.2
-
28
-
-
65649108414
-
A review of the pathways underlying the association between asthma and major depressive disorder
-
Van Lieshout R.J., Bienenstock J., and MacQueen G.M. A review of the pathways underlying the association between asthma and major depressive disorder. Psychosom Med 71 (2009) 187-195
-
(2009)
Psychosom Med
, vol.71
, pp. 187-195
-
-
Van Lieshout, R.J.1
Bienenstock, J.2
MacQueen, G.M.3
-
29
-
-
0033600291
-
Characterization of the human cysteinyl leukotriene CysLT1 receptor
-
Lynch K.R., O'Neill G.P., Liu Q., Im D.-S., Sawyer N., Metters K.M., et al. Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature 399 (1999) 789-883
-
(1999)
Nature
, vol.399
, pp. 789-883
-
-
Lynch, K.R.1
O'Neill, G.P.2
Liu, Q.3
Im, D.-S.4
Sawyer, N.5
Metters, K.M.6
-
30
-
-
0029063884
-
Pharmacology of montelukast sodium (Singulair), a potent and selective leukotriene D4 receptor antagonist [published erratum in: Can J Physiol Pharmacol 1995;73:747]
-
Jones T.R., Labelle M., Belley M., Champion E., Charette L., Evans J., et al. Pharmacology of montelukast sodium (Singulair), a potent and selective leukotriene D4 receptor antagonist [published erratum in: Can J Physiol Pharmacol 1995;73:747]. Can J Physiol Pharmacol 73 (1995) 191-201
-
(1995)
Can J Physiol Pharmacol
, vol.73
, pp. 191-201
-
-
Jones, T.R.1
Labelle, M.2
Belley, M.3
Champion, E.4
Charette, L.5
Evans, J.6
-
31
-
-
33646795009
-
Increased expression of cysteinyl leukotriene receptor-1 in the brain mediates neuronal damage and astrogliosis after focal cerebral ischemia in rats
-
Fang S.H., Wei E.Q., Zhou Y., Wang M.L., Zhang W.P., Yu G.L., et al. Increased expression of cysteinyl leukotriene receptor-1 in the brain mediates neuronal damage and astrogliosis after focal cerebral ischemia in rats. Neuroscience 140 (2006) 969-979
-
(2006)
Neuroscience
, vol.140
, pp. 969-979
-
-
Fang, S.H.1
Wei, E.Q.2
Zhou, Y.3
Wang, M.L.4
Zhang, W.P.5
Yu, G.L.6
-
32
-
-
33749323854
-
The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor
-
Ciana P., Fumagalli M., Trincavelli M.L., Verderio C., Rosa P., Lecca D., et al. The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor. EMBO J 25 (2006) 4615-4627
-
(2006)
EMBO J
, vol.25
, pp. 4615-4627
-
-
Ciana, P.1
Fumagalli, M.2
Trincavelli, M.L.3
Verderio, C.4
Rosa, P.5
Lecca, D.6
-
33
-
-
56349145808
-
The recently identified P2Y-like receptor GPR17 is a sensor of brain damage and a new target for brain repair
-
e3579
-
Lecca D., Trincavelli M.L., Gelosa P., Sironi L., Ciana P., Fumagalli M., et al. The recently identified P2Y-like receptor GPR17 is a sensor of brain damage and a new target for brain repair. PLoS ONE 3 (2008) e3579
-
(2008)
PLoS ONE
, vol.3
-
-
Lecca, D.1
Trincavelli, M.L.2
Gelosa, P.3
Sironi, L.4
Ciana, P.5
Fumagalli, M.6
-
35
-
-
0036032974
-
5-lipoxygenase (5LOX)-deficient mice express reduced anxiety-like behavior
-
Uz T., Dimitrijevic N., Tueting P., and Manev H. 5-lipoxygenase (5LOX)-deficient mice express reduced anxiety-like behavior. Restor Neurol Neurosci 20 (2002) 15-20
-
(2002)
Restor Neurol Neurosci
, vol.20
, pp. 15-20
-
-
Uz, T.1
Dimitrijevic, N.2
Tueting, P.3
Manev, H.4
-
36
-
-
41949100044
-
Effects of MK-866, a 5-liopoxygenase activating protein (FLAP) inhibitor, and 5-lipoxygenase deficiency on the forced swimming behavior of mice
-
Uz T., Dimitrijevic N., Imbesi M., Manev H., and Manev R. Effects of MK-866, a 5-liopoxygenase activating protein (FLAP) inhibitor, and 5-lipoxygenase deficiency on the forced swimming behavior of mice. Neurosci Lett 436 (2008) 269-272
-
(2008)
Neurosci Lett
, vol.436
, pp. 269-272
-
-
Uz, T.1
Dimitrijevic, N.2
Imbesi, M.3
Manev, H.4
Manev, R.5
-
37
-
-
71749121480
-
5-Lipoxygenase in the prefrontal cortex of suicide victims
-
Uz T., Dwivedi Y., Pandey G.N., Roberts R.C., Conley R.R., Manev R., et al. 5-Lipoxygenase in the prefrontal cortex of suicide victims. Open Neuropsychopharmacol J 1 (2008) 1-5
-
(2008)
Open Neuropsychopharmacol J
, vol.1
, pp. 1-5
-
-
Uz, T.1
Dwivedi, Y.2
Pandey, G.N.3
Roberts, R.C.4
Conley, R.R.5
Manev, R.6
|